Structure-activity relationships in side-chain-modified epothilone analogues - How important is the position of the nitrogen atom?

ChemMedChem

Volumn 1, Issue 1, 2006, Pages 37-40

  Bold, Guido ^b   Wojeik, Séverine ^b   Caravatti, Giorgio ^b   Lindauer, Renate ^a   Stierlin, Claire ^a   Gertsch, Jürg ^a   Wartmann, Markus ^b   Altmann, Karl Heinz ^a  

^a ETH ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antitumor agents; Epothilones; Natural products; Structure activity relationships; Total synthesis

Indexed keywords

EPOTHILONE DERIVATIVE; NITROGEN;

ARTICLE; CHEMISTRY; STRUCTURE ACTIVITY RELATION;

EPOTHILONES; NITROGEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746306765     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200500051     Document Type: Article

References (34)

1. For recent reviews, see: a) K.-H. Altmann, Curr. Pharm. Des. 2005, 11, 1595-1613;
2. b) K.-H. Altmann, Org. Biomol. Chem. 2004, 2, 2137-2152;
3. c) A. Rivkin, T.-C. Chou, S. J. Danishefsky, Angew. Chem. 2005, 117, 2898-2910;
4. Angew. Chem. Int. Ed. 2005, 44, 2838-2850;
5. d) R. M. Borzilleri, G. D. Vite, Drugs of the Future 2003, 28, 1149-1163;
6. e) M. Wartmann, K.-H. Altmann, Curr. Med. Chem. Anti-Cancer Agents 2002, 2, 123-148;
7. f) C. R. Harris, S. J. Danishefsky, J. Org. Chem. 1999, 64, 8434-8456;
8. g) K. C. Nicolaou, F. Roschangar, D. Vourloumis, Angew. Chem. 1998, 110, 2120-2153;
9. Angew. Chem. Int. Ed. 1998, 37, 2014-2045.
10. a) G. Höfle, N. Bedorf, K. Gerth, H. Reichenbach, DE 4138042, May 5, 1993 (Priority Nov. 19, 1991);
11. b) K. Gerth, N. Bedorf, G. Höfle, H. Irschik, H. Reichenbach, J. Antibiot. 1996, 49, 560-564.
12. D. M. Bollag, P. A. McQueney, J. Zhu, O. Hensens, L. Koupal, J. Liesch, M. Goetz, E. Lazarides, C. M. Woods, Cancer Res. 1995, 55, 2325-2333.
13. E. K. Rowinsky, Annu. Rev. Med. 1997, 48, 353-374.
14. K. C. Nicolaou, R. Scarpelli, B. Bollbuck, B. Werschkun, M. M. Pereira, M. Wartmann, K.-H. Altmann, D. Zaharevitz, R. Gussio, P. Giannakakou, Chem. Biol. 2000, 7, 593-599.
15. J. H. Nettles, H. Li, J. M. Krahn, J. P. Snyder, K. H. Downing, Science 2004, 305, 866-869.
16. T. Carlomagno, M. J. J. Blommers, J. Meiler, W. Jahnke, T. Schupp, F. Petersen, D. Schinzer, K.-H. Altmann, C. Griesinger, Angew. Chem. 2003, 115, 2515-2519;
17. Angew. Chem. Int. Ed. 2003, 42, 2511-2515.
18. K.-H. Altmann, G. Bold, G. Caravatti, A. Flörsheimer, V. Guagnano, M. Wartmann, Bioorg. Med. Chem. Lett. 2000, 10, 2765-2768.
19. Compound 1 a was independently reported by the Schering group: Anticancer Agents-Frontiers in Cancer Chemotherapy: U. Klar, W. Skuballa, B. Buchmann, W. Schwede, T. Bunte, J. Hoffmann, R. Lichtner, ACS Symp. Ser. 2001, 796, 131-147.
20. Epo D is the 12/13-deoxy derivative of Epo B; it incorporates a cis double bond between C12 and C13 in place of an epoxide moiety.
21. a) K.-H. Altmann, G. Bold, G. Caravatti, D. Denni, A. Flörsheimer, A. Schmidt, G. Rihs, M. Wartmann, Helv. Chim. Acta 2002, 85, 4086-4110;
22. b) D. Schinzer, A. Bauer, A. Limberg, Chem. Eur. J. 1999, 5, 2492-2500.
23. K. C. Nicolaou, S. Ninkovic, F. Sarabia, D. Vourloumis, Y. He, H. Vallberg, M. R. V. Finlay, Z. Yang, J. Am. Chem. Soc. 1997, 119, 7974-7991.
24. Compound 7 was prepared from the known 2,6-dimethyl-benzothiazole (M.J. Spitulnik, Synthesis 1976, 730-731) by light-catalyzed bromination with NBS (W lamp, 80 C, 4 h) and subsequent treatment of the brominated intermediate with AcOH and hexamethylene tetraamine (2 h, 36%).
25. a) S. Bond, P. Perlmutter, J. Org. Chem. 1997, 62, 6397-6400;
26. b) W. Oppolzer, Pure Appl. Chem. 1990, 62, 1241-1250.
27. J. Chen, T. Wang, K. Zhao, Tetrahedron Lett. 1994, 35, 2827-2828.
28. J. Inanaga, K. Hirata, H. Saeki, T. Katsuki, M. Yamaguchi, Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993.
29. 2 at 160 C) analogously to the synthesis of 6. Details of the synthesis of 14 will be published elsewhere.
30. J. Rudolph, K. L. Reddy, J. P. Chang, K. B. Sharpless, J. Am. Chem. Soc. 1997, 119, 6189-6190.
31. R. B. Lichtner, A. Rotgeri, T. Bunte, B. Buchmann, J. Hoffmann, W. Schwede, W. Skuballa, U. Klar, Proc. Natl. Acad. Sci. USA 2001, 98, 11743-11748.
32. C. M. Lin, Y. Q. Jiang, A. G. Chaudhary, J. M. Rimoldi, D. G. Kingston, E. Hamel, Cancer Chemother. Pharmacol. 1996, 38, 136-140.
33. E. Hamel, A. A. Del Campo, J. Lustbader, C. M. Lin, Biochemistry 1983, 22, 1271-1279.
34. a) T. Meyer, U. Regenass, D. Fabbro, E. Alteri, J. Rösel, M. Müller, G. Caravatti, A. Matter, Int. J. Cancer 1989, 43, 851-856.